ArticlePediatric obesity2025
Development and application of a cost tool for a primary care-based intensive health behaviour and lifestyle treatment.
Article in Pediatric obesity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Disseminating and Implementing the Science of Pediatric Obesity Treatment and Prevention.Obesity (Silver Spring, Md.) · 2026Article
- Considerations for Cost Assessment of Implementing Family Healthy Weight Programs Across Community and Clinical Contexts.Childhood obesity (Print) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveThis paper aims to describe the development and application of a cost tool to help predict return on investment and sustainability of the Healthy Weight Clinic Family Healthy Weight Program (FHWP) through insurance reimbursement.
methodsCase studies to apply the cost tool were conducted with 3 sites to assess the break-even point for clinic patient volume (i.e., financial neutral point: operational costs = revenue) during implementation. Financial neutral points were based on average reimbursement rates per health centre.
resultsThe annual fixed cost of the intervention ranged from $65 252 to $79 024. The average revenue ranged from $806-$1663 per patient through medical reimbursement, and the clinics needed to care for an average of 37-81 patients annually to break even.
conclusionsUse of an adaptable cost tool that captures reimbursement of clinical provider time and a minimum stream of clinical volume can equip decision-makers in planning financially to implement and sustain a clinically based FHWP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.